Applied Biomath Inc., of Concord, Mass., disclosed an agreement with Verseau Therapeutics Inc., of Bedford, Mass., for the delivery of systems pharmacology pharmacokinetic and target engagement analysis to provide early feasibility assessments for the treatment of cancer. Financial terms were not disclosed.